insights_auto
Bakit bumaba ang OLY1 12.41%?
Tingnan ang Higit pang Detalyechevron_right
OLY1:FRA
Olympus Corporation
€10.02
arrow_downward
-12.41%(-1.42) 1D
Okt 14, 10:22:19 AM GMT+2 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa OLY1...
Buksan
€9.80
Mataas
€10.02
Mababa
€9.80
Mkt. cap
12.14B
Avg. na dami
15.00
Dami
1.74K
Mataas nang 52-wk
€11.74
Mababa nang 52-wk
€7.01
Bilang ng mga empleyado
28K
Buksan
€9.80
Mataas
€10.02
Mababa
€9.80
Mkt. cap
12.14B
Avg. na dami
15.00
Dami
1.74K
Mataas nang 52-wk
€11.74
Mababa nang 52-wk
€7.01
Bilang ng mga empleyado
28K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Financial Times
·
8 oras ang nakalipas
Olympus shares suffer biggest drop since 2011 after FDA warning
Yahoo Finance
·
11 oras ang nakalipas
Olympus shares hit 12-week low after FDA warning over quality systems
Investing.com
·
12 oras ang nakalipas
Why is Olympus stock plunging today?
Bloomberg.com
·
14 oras ang nakalipas
Olympus Shares Plunge After FDA Warning Letter on Six Facilities
Profile
Olympus Corporation is a Japanese manufacturer of optics and reprography products, headquartered in Hachioji, Tokyo. Olympus was founded on October 12, 1919 as Takachiho Seisakusho by Takeshi Yamashita, initially specializing in microscopes and thermometers, and later in imaging. In 1921, the name Olympus was registered as a trademark. In 1942, the company was renamed Takachiho Optical Industries, and in 1949 it was renamed Olympus Optical Co., Ltd. In 2003, the company adopted its current name, Olympus Corporation.
Olympus holds roughly a 70 percent share of the global endoscope market, estimated to be worth approximately US$2.5 billion. As of 2025, endoscopes and related surgical technologies are now Olympus's exclusive product line. It was formerly also a maker of cameras, camera lenses and dictaphones, until it divested this part to OM Digital Solutions in 2020. It divested from its microscopy and scientific imaging division in 2023, selling it to Bain Capital for approximately $3.1 billion; the division operates as Evident Corporation. Wikipedia
Tungkol sa Olympus Corporation